EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond Ketosis: Dietary Therapies and the Microbiota–Gut–Brain Axis in Epilepsy

Valentina Biagioli iD, Mariarosaria Matera iD, Ilaria Imola, Federica Mela, Damiano Lemmi, Alberto Verrotti, Pasquale Striano iD

Nutrients · 02.07.2026 · 18 (13) · 2151

DOI: 10.3390/nu18132151 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 02.07.2026. Verfasst von Valentina Biagioli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, 16126 Genoa, Italy. Hauptthemen laut MEDLINE: Epilepsy, Gastrointestinal Microbiome, Ketosis, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epilepsy is a complex neurological disorder in which growing evidence supports a significant role for the microbiota–gut–brain axis (MGBA) in modulating neuroinflammation, neuronal excitability, and treatment responsiveness. Beyond their traditional role in inducing ketosis, dietary therapies may influence epilepsy by modulating gut microbial ecology, intestinal barrier integrity, immune signaling, and microbiota-derived metabolites.

Methods

This narrative review critically examines current clinical and experimental evidence regarding the relationship between epilepsy, gut microbiota, and dietary interventions. Particular attention was given to ketogenic dietary therapies, the Modified Atkins Diet (MAD), low-glycemic-index treatment (LGIT), Mediterranean dietary patterns, restrictive diets, and microbiota-targeted supplementation, including probiotics, prebiotics, and postbiotics.

Results

Available evidence suggests that patients with epilepsy exhibit alterations in gut microbial composition associated with impaired short-chain fatty acid production, intestinal inflammation, and altered neuroimmune regulation. Ketogenic and microbiota-supportive dietary approaches may modulate these pathways beyond ketosis alone, potentially contributing to seizure reduction through integrated metabolic, inflammatory, and microbial mechanisms. Emerging evidence also supports a role for probiotics, prebiotics, and postbiotics in modulating gut–brain communication and neuroinflammatory signaling, although current clinical data remain limited.

Conclusions

Dietary therapies in epilepsy should no longer be viewed exclusively as metabolic interventions aimed at inducing ketosis, but rather as potential modulators of the microbiota–gut–brain axis and neuroimmune homeostasis. While further mechanistic and clinical studies are needed, microbiota-targeted nutritional approaches may represent valuable complementary strategies to be integrated alongside conventional antiseizure therapies within more personalized models of epilepsy management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyGastrointestinal MicrobiomeKetosisBrainBrain-Gut AxisHumansDiet, KetogenicProbioticsPrebioticsAnimalsDiet, Carbohydrate-RestrictedDiet, MediterraneanDiet, High-Protein Low-Carbohydrate

Stichwörter der Autor:innen

epilepsyketogenic dietlow glycemic index treatmentmicrobiota–gut–brain axismodified Atkins dietneuroinflammation

Substanzen

Prebiotics

Autor:innen und Institutionen

  • Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, 16126 Genoa, Italy.
  • Department of Pediatric Emergencies, Misericordia Hospital, 58100 Grosseto, Italy.
  • Child Neuropsychiatry Unit, Department of Mental Health, Physical and Preventive Medicine, University of Campania "Luigi Vanvitelli", 81100 Caserta, Italy.
  • Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health (DINOGMI), University of Genoa, 16126 Genoa, Italy.
  • Department of Paediatrics, University of Perugia, 06123 Perugia, Italy.
  • Pediatric Neurology and Muscular Diseases Unit, Scientific Institute for Research, Hospitalization and Health Care (IRCCS) Istituto Giannina Gaslini, 16147 Genoa, Italy.

ORCID-Profile: Valentina Biagioli, Mariarosaria Matera, Pasquale Striano

Zitieren

APA

Biagioli, V., Matera, M., Imola, I., Mela, F., Lemmi, D., Verrotti, A., & Striano, P. (2026). Beyond Ketosis: Dietary Therapies and the Microbiota–Gut–Brain Axis in Epilepsy. Nutrients, 18(13), 2151. https://doi.org/10.3390/nu18132151

Vancouver

Biagioli V, Matera M, Imola I, Mela F, Lemmi D, Verrotti A, et al. Beyond Ketosis: Dietary Therapies and the Microbiota–Gut–Brain Axis in Epilepsy. Nutrients. 2026;18(13):2151. doi:10.3390/nu18132151

BibTeX
@article{Biagioli2026,
  author = {Biagioli, Valentina and Matera, Mariarosaria and Imola, Ilaria and Mela, Federica and Lemmi, Damiano and Verrotti, Alberto and Striano, Pasquale},
  title = {Beyond Ketosis: Dietary Therapies and the Microbiota–Gut–Brain Axis in Epilepsy},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {13},
  pages = {2151},
  doi = {10.3390/nu18132151}
}
Kostenlos starten →